Avidity Biosciences, Inc. short interest in 2024
In 2024, Avidity Biosciences, Inc.'s disclosed short interest ran from 9.90% of shares outstanding on 12 Jan 2024 to 13.15% on 31 Dec 2024, a change of +3.25 percentage points. The year's high was 14.39% on 15 Apr 2024 and its low 9.84% on 30 Aug 2024, averaging 11.95% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.95 days on 31 Oct 2024. Full history: Avidity Biosciences, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 9.90% (12 Jan 2024)
- End of year
- 13.15% (31 Dec 2024)
- Change
- +3.25 pp
- High
- 14.39% (15 Apr 2024)
- Low
- 9.84% (30 Aug 2024)
- Average
- 11.95%
- Highest days to cover
- 19.95 (31 Oct 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 9.90% | 5.65 | |
| 31 Jan 2024 | 10.31% | 7.42 | |
| 15 Feb 2024 | 10.43% | 9.70 | |
| 29 Feb 2024 | 10.48% | 7.09 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 11.63% | 4.75 | |
| 28 Mar 2024 | 13.47% | 7.85 | |
| 15 Apr 2024 | 14.39% | 10.62 | |
| 30 Apr 2024 | 11.91% | 12.84 | |
| 15 May 2024 | 11.82% | 11.24 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.32% | 10.83 | |
| 14 Jun 2024 | 11.78% | 4.63 | |
| 28 Jun 2024 | 11.33% | 4.27 | |
| 15 Jul 2024 | 13.49% | 9.89 | |
| 31 Jul 2024 | 11.80% | 11.90 | |
| 15 Aug 2024 | 11.77% | 9.48 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 9.84% | 8.18 | |
| 13 Sep 2024 | 10.91% | 12.26 | |
| 30 Sep 2024 | 13.46% | 6.18 | |
| 15 Oct 2024 | 13.56% | 17.00 | |
| 31 Oct 2024 | 12.29% | 19.95 | |
| 15 Nov 2024 | 12.17% | 10.39 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 12.52% | 16.44 | |
| 13 Dec 2024 | 12.97% | 12.15 | |
| 31 Dec 2024 | 13.15% | 11.07 |
See also: Avidity Biosciences, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.